N-acetylglucosamine modification in the lumen of the endoplasmic reticulum.
N-acetylglucosamine modification in the lumen of the endoplasmic reticulum.
复制标题
DOI:
10.1016/j.bbagen.2015.03.003
复制
发表时间:
2015-06
期刊:
影响因子:
--
通讯作者:
Mitsutaka Ogawa;Shogo Sawaguchi;K. Furukawa;T. Okajima
中科院分区:
文献类型:
--
作者:
Mitsutaka Ogawa;Shogo Sawaguchi;K. Furukawa;T. Okajima
BackgroundO-linked β-N-acetylglucosamine (O-GlcNAc) modification of epidermal growth factor (EGF) domains catalyzed by EGF domain O-GlcNAc transferase (EOGT) is the first example of GlcNAc modification in the lumen of the endoplasmic reticulum (ER).Scope of reviewThis review summarizes current knowledge on the EOGT-catalyzed O-GlcNAc modification of EGF domains obtained through biochemical characterization, genetic analysis inDrosophila, and identification of humanEOGTmutation. Additionally, this review discusses GTDC2—another ER protein homologous to EOGT that catalyzes the GlcNAc modification of O-mannosylated α-dystroglycan—and other components of the biosynthetic pathway involved in GlcNAc modification in the ER lumen.Major conclusionsGlcNAc modification in the ER lumen has been identified as a novel type of protein modification that regulates specific protein function. Moreover, abnormal GlcNAc modification in the ER lumen is responsible for Adams–Oliver syndrome and Walker–Warburg syndrome.General significanceElucidation of the biological function of GlcNAc modification in the ER lumen will provide new insights into the unique roles of O-glycans, whose importance has been demonstrated in multifunctional glycoproteins such as Notch receptors and α-dystroglyan.